|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-10-23
|
|
pubmed:abstractText |
Studies have shown fluticasone propionate (FP) 100, 200, and 500 microg administered once daily to be effective in the treatment of asthma. The efficacy of a once daily regimen of FP 250 microg has not been evaluated previously.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1081-1206
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
393-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12392384-Administration, Oral,
pubmed-meshheading:12392384-Adolescent,
pubmed-meshheading:12392384-Adult,
pubmed-meshheading:12392384-Aged,
pubmed-meshheading:12392384-Aged, 80 and over,
pubmed-meshheading:12392384-Androstadienes,
pubmed-meshheading:12392384-Anti-Inflammatory Agents,
pubmed-meshheading:12392384-Asthma,
pubmed-meshheading:12392384-Bronchodilator Agents,
pubmed-meshheading:12392384-Child,
pubmed-meshheading:12392384-Double-Blind Method,
pubmed-meshheading:12392384-Drug Therapy, Combination,
pubmed-meshheading:12392384-Female,
pubmed-meshheading:12392384-Forced Expiratory Volume,
pubmed-meshheading:12392384-Humans,
pubmed-meshheading:12392384-Male,
pubmed-meshheading:12392384-Middle Aged,
pubmed-meshheading:12392384-Peak Expiratory Flow Rate,
pubmed-meshheading:12392384-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids.
|
|
pubmed:affiliation |
weberger@uci.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
